Thank you to our speakers, sponsors, and delegates who joined us at the 3rd Donor Selection & Cell Source Summit
If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Download the 2025 program to uncover the strategies that tackled your top challenges across donor selection and cell sourcing, including:
- Tools to nail characterization testing with insights from Immunebridge
- Insights into the investment landscape from Allogene Therapeutics
- Real data on how other companies like Luminary Therapeutics and Genentech are using starting material
And learn more about the solution providers invested in allogeneic success.
*If you are having issues downloading the agenda,
get in touch here.
Companies In The Program Included:
What Content Was Covered?
The program has been designed alongside top industry KOLs to deliver practical and forward-thinking content.
Here are just a few highlights:
Next-gen computational tools for donor screening to improve efficiency and predict product outcomes with greater accuracy
Defining the “super donor” and understanding factors driving starting material quality so your criteria is based on data, not stereotypes
Managing donor variability across PBMCs, iPSCs, and cord blood, with case studies from leading allogeneic developers
Funding and investment strategies with seasoned investors who’ve successfully guided companies through the current market landscape
Meet the Solution Providers Supporting Allogeneic Development:
